Naseer, Asif (2015) Gammaretrovirus Replication in Human Cells: Implications for Experimental Xenografts and Risk of Zoonosis.Phd Thesis

Total Page:16

File Type:pdf, Size:1020Kb

Naseer, Asif (2015) Gammaretrovirus Replication in Human Cells: Implications for Experimental Xenografts and Risk of Zoonosis.Phd Thesis Naseer, Asif (2015) Gammaretrovirus replication in human cells: implications for experimental xenografts and risk of zoonosis.PhD thesis. http://theses.gla.ac.uk/6279/ . Copyright and moral rights for this thesis are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Glasgow Theses Service http://theses.gla.ac.uk/ [email protected] Gammaretrovirus replication in human cells: Implications for experimental xenografts and risk of zoonosis Submitted to the University of Glasgow In fulfilment of the requirements of the degree of PhD November 2014 Dr. Asif Naseer, M.B.B.S., PgDip Evidence Based Medicine & HPE. Molecular Oncology Lab Centre for Virus Research Institute of Infection, Immunity and Inflammation College of Medical, Veterinary and Life Sciences 2 Acknowledgement Thank You God for being so merciful and giving me the strength and inspiration required. I would like to thank my supervisors Ewan Cameron and James Neil for giving me the opportunity to undertake this project and for providing me their continuous unlimited support, encouragement, guidance and advice throughout the whole time. I really feel words cannot do justice in expressing my sincere gratitude. I am really grateful to my laboratory supervisor Anne Terry, for her continued assistance and encouragement whenever I needed. By working in the Molecular Oncology Lab, I really feel I had the best colleagues one can ever have. Anna Kilbey was always there to provide all sorts of academic and moral support through all the tough times of PhD. Nancy Mackay was always ready to provide guidance in the lab, and assistance in molecular biology procedures. I would like to thank Margaret Bell for her help in collecting samples, Alma for all sorts of assistance and Kathryn for helping me to interpret the expression analysis experiments. I would also like to thank Gillian Borland for her help in flow cytometry and for all the cakes that always kept me energized while working late hours. I really feel I was really very lucky to find such a friendly place to work. I would also like to thank Karen Blyth and Susan Mason (Beatson) for their regular help in xenograft experiments and Pamela Kearns (University of Birmingham) for kindly providing me precious primary samples and Sam Wilson for his advice in different experiments. I am grateful to the Khyber Medical University for funding my PhD program and Prof Hafiz Ullah for his support and interest in my project. Finally I will like to thank all my friends; Jaffer, Hamid, Inayat, Asif, Yassar, Ahsen, Shahzad, Zia and especially Dr Omar Malik for their moral and spiritual support. Last but not least I will like to thank my family (both in Glasgow and back home in Peshawar) for their patience and support, especially my father Naseer Ahmad and my mother Khalida Khanum who always believed in me and have always encourage me to work hard and my aunt Jameela and uncle Haroon Khan for their support when I needed it the most. 3 Author’s declaration I declare that this thesis is the result of my own work unless otherwise stated. This dissertation has not been submitted for any other degree at the University of Glasgow or any other institute. Part of this thesis has been submitted for publication in the journal ‘Viruses’. 4 Table of contents Acknowledgement .......................................................................... 2 Author’s declaration ....................................................................... 3 Table of contents ........................................................................... 4 List of tables ................................................................................ 8 List of figures ............................................................................... 9 List of techniques I used in this study .................................................. 11 Abbreviations .............................................................................. 13 Abstract ..................................................................................... 16 1 Introduction ........................................................................... 18 1.1 Retroviruses ..................................................................... 18 1.1.1 Structure and classification of retroviruses ........................... 18 1.1.2 Replication cycle of retroviruses ........................................ 20 1.1.3 Exogenous and endogenous retroviruses ............................... 22 1.2 Host resistance .................................................................. 25 1.2.1 The innate and adaptive immune systems ............................ 25 1.2.2 The intrinsic immune system ............................................ 26 1.3 Gammaretroviruses as potential zoonotic agents .......................... 31 1.3.1 Human fossil viruses ...................................................... 31 1.3.2 Koala retrovirus: A recent example of trans-species infection ..... 32 1.3.3 Porcine endogenous retroviruses: A potential zoonotic agent ..... 32 1.3.4 Potentially widespread human exposure to feline leukaemia virus 33 1.3.5 XMRV controversy and its aftermath: XMLV found in human xenografts ............................................................................. 34 1.4 Xenografting and cancer research ........................................... 35 1.4.1 Infection of xenografts ................................................... 35 1.4.2 Retroviral insertional mutagenesis ..................................... 36 1.5 Aims of the study ............................................................... 38 1.5.1 To conduct a prospective study of the risks of acquiring XMLV infection in human cancer xenografts. ........................................... 38 1.5.2 To investigate the susceptibility of human cells to FeLV and XMLV in vitro. 38 1.5.3 To investigate the mechanisms of resistance of human cells to FeLV and XMLV. ............................................................................. 39 1.5.4 To examine the significance of XMLV infection for human xenograft behaviour. ............................................................................. 39 2 Materials and methods .............................................................. 40 2.1 Materials ......................................................................... 40 5 2.1.1 Cell culture ................................................................. 40 2.1.2 Chemically competent bacteria ......................................... 44 2.1.3 Commercial kits ........................................................... 44 2.1.4 Buffers, solutions and reagents ......................................... 45 2.1.5 Enzymes .................................................................... 46 2.1.6 Antibiotics .................................................................. 47 2.1.7 Antibodies .................................................................. 47 2.2 Methods .......................................................................... 47 2.2.1 Infecting cells with virus ................................................. 47 2.2.2 Confirmation of virus infection.......................................... 49 2.2.3 Virus titration .............................................................. 49 2.2.4 Xenografting human cells into mice .................................... 50 2.2.5 Molecular biology .......................................................... 51 3 Infection of human xenografts with XMLV ........................................ 70 3.1 Introduction ..................................................................... 70 3.2 Materials and methods ......................................................... 71 3.3 Results ............................................................................ 71 3.3.1 MCF7 cells xenografted into BALB/c mice become infected with XMLV 71 3.3.2 Primary childhood leukaemia cells passaged in NSG mice show no evidence of XMLV infection. ........................................................ 77 3.3.3 THP-1 cells xenografted into NSG mice do not become infected with XMLV ............................................................................. 78 3.3.4 The Bxv1 provirus is present in BALB/c and C57BL mice but not in NSG mice .............................................................................. 81 3.3.5 MCF7 cells do not get infected with XMLV when passaged in NSG mice but may acquire a non-replication competent defective virus ......... 83 3.3.6 Raji cells xenografted into BALB/c mice formed regressing tumour nodules 88 3.4 Discussion ........................................................................ 88 4 Susceptibility of human cells to XMLV infection ................................. 91 4.1 Introduction ..................................................................... 91 4.2 Materials and methods ......................................................... 91 4.3 Results ............................................................................ 91 4.3.1 XPR1 receptor expression ...............................................
Recommended publications
  • Interactions of Zinc with the Intestinal Epithelium - Effects On
    Aus dem Institut für Veterinär-Physiologie des Fachbereichs Veterinärmedizin der Freien Universität Berlin Interactions of zinc with the intestinal epithelium - effects on transport properties and zinc homeostasis Inaugural-Dissertation zur Erlangung des Grades eines Doktors der Veterinärmedizin an der Freien U niversität Berlin vorgelegt von Eva-Maria Näser, geb. Gefeller Tierärztin aus Kassel Berlin 2015 Journal-Nr.: 3813 Gefördert durch die Deutsche Forschungsgemeinschaft und die H.W. Schaumann Stiftung Gedruckt mit Genehmigung des Fachbereichs Veterinärmedizin der Freien Universität Berlin Dekan: Univ.-Prof. Dr. Jürgen Zentek Erster Gutachter: Univ.-Prof. Dr. Jörg Rudolf Aschenbach Zweiter Gutachter: Prof. Dr. Holger Martens Dritter Gutachter: Prof. Dr. Robert Klopfleisch Deskriptoren (nach CAB-Thesaurus): pigs, weaning, zinc, intestines, epithelium, jejunum, ion transport Tag der Promotion: 15.09.2015 Bibliografische Information der Deutschen Nationalbibliothek Die Deutsche Nationalbibliothek verzeichnet diese Publikation in der Deutschen Nationalbibliografie; detaillierte bibliografische Daten sind im Internet über <http://dnb.ddb.de> abrufbar. ISBN: 978-3-86387-656-2 Zugl.: Berlin, Freie Univ., Diss., 2015 Dissertation, Freie Universität Berlin D 188 Dieses Werk ist urheberrechtlich geschützt. Alle Rechte, auch die der Übersetzung, des Nachdruckes und der Vervielfältigung des Buches, oder Teilen daraus, vorbehalten. Kein Teil des Werkes darf ohne schriftliche Genehmigung des Verlages in irgendeiner Form reproduziert oder unter Verwendung elektronischer Systeme verarbeitet, vervielfältigt oder verbreitet werden. Die Wiedergabe von Gebrauchsnamen, Warenbezeichnungen, usw. in diesem Werk berechtigt auch ohne besondere Kennzeichnung nicht zu der Annahme, dass solche Namen im Sinne der Warenzeichen- und Markenschutz-Gesetzgebung als frei zu betrachten wären und daher von jedermann benutzt werden dürfen. This document is protected by copyright law.
    [Show full text]
  • Investigating the Genetic Basis of Cisplatin-Induced Ototoxicity in Adult South African Patients
    --------------------------------------------------------------------------- Investigating the genetic basis of cisplatin-induced ototoxicity in adult South African patients --------------------------------------------------------------------------- by Timothy Francis Spracklen SPRTIM002 SUBMITTED TO THE UNIVERSITY OF CAPE TOWN In fulfilment of the requirements for the degree MSc(Med) Faculty of Health Sciences UNIVERSITY OF CAPE TOWN University18 December of Cape 2015 Town Supervisor: Prof. Rajkumar S Ramesar Co-supervisor: Ms A Alvera Vorster Division of Human Genetics, Department of Pathology, University of Cape Town 1 The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgement of the source. The thesis is to be used for private study or non- commercial research purposes only. Published by the University of Cape Town (UCT) in terms of the non-exclusive license granted to UCT by the author. University of Cape Town Declaration I, Timothy Spracklen, hereby declare that the work on which this dissertation/thesis is based is my original work (except where acknowledgements indicate otherwise) and that neither the whole work nor any part of it has been, is being, or is to be submitted for another degree in this or any other university. I empower the university to reproduce for the purpose of research either the whole or any portion of the contents in any manner whatsoever. Signature: Date: 18 December 2015 ' 2 Contents Abbreviations ………………………………………………………………………………….. 1 List of figures …………………………………………………………………………………... 6 List of tables ………………………………………………………………………………….... 7 Abstract ………………………………………………………………………………………… 10 1. Introduction …………………………………………………………………………………. 11 1.1 Cancer …………………………………………………………………………….. 11 1.2 Adverse drug reactions ………………………………………………………….. 12 1.3 Cisplatin …………………………………………………………………………… 12 1.3.1 Cisplatin’s mechanism of action ……………………………………………… 13 1.3.2 Adverse reactions to cisplatin therapy ……………………………………….
    [Show full text]
  • ( 12 ) United States Patent
    US007459539B2 ( 12) United States Patent ( 10 ) Patent No. : US 7 , 459 ,539 B2 Challita - Eid et al. (45 ) Date of Patent: Dec. 2 , 2008 ( 54 ) ANTIBODY THAT BINDS ZINC WO WO 03050236 6 / 2003 TRANSPORTER PROTEIN 108P5H8 ( 75 ) Inventors : Pia M . Challita - Eid , Encino , CA (US ) ; OTHER PUBLICATIONS Mary Faris , Los Angeles , CA (US ) ; Murgia et al . Cloning, expression , and vesicular localization of zinc Daniel E . H . Afar , Brisbane , CA (US ) ; transporter Dri 27 /ZnT4 in intestinal tissue and cells . Am J Physiol Rene S . Hubert , Los Angeles , CA (US ) ; 277 (Gastrointest Liver Physiol 40 ) : G1231 -61239 , 1999 . * Steve Chappell Mitchell, Gurnee , IL Kaufman et al. Blood 9 : 3178 -3184 , 1999 . * (US ) ; Elana Levin , Los Angeles, CA Wang et al . Rapid analysis of gene expression (RAGE ) facilitates (US ) ; Karen Jane Meyrick Morrison , universal expression profiling . Nucleic Acids Res 27 (23 ) : 4609 4618 , 1999 . * Santa Monica , CA (US ) ; Arthur B . Campbell et al. Totipotency of multipotentiality of cultured cells : Raitano , Los Angeles , CA (US ) ; Aya applications and progress . Theriogenology 47 : 63 -72 , 1997 . * Jakobovits , Beverly Hills , CA (US ) Moore , G . Genetically engineered antibodies. Clin Chem 35 ( 9 ) : 1849 - 1853 , 1989 . * (73 ) Assignee : Agensys, Inc ., Santa Monica , CA (US ) Dillman et al .Monoclonal antibodies in the treatment ofmalignancy : basic concepts and recent developments . Cancer Invest 19 ( 8 ) : 833 ( * ) Notice: Subject to any disclaimer, the term of this 841, 2001. * patent is extended or adjusted under 35 Skolnick et al. From genes to protein structure and function : novel U . S . C . 154 ( b ) by 1273 days . applications of computational approaches in the genomic era .
    [Show full text]
  • Clinical Study Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex
    Neuron, Vol. 28, 53±67, October, 2000, Copyright 2000 by Cell Press Molecular Characterization of Clinical Study Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex Ka roly Mirnics,*³§ Frank A. Middleton,* pus, superior temporal gyrus, and thalamus, appear to Adriana Marquez,* David A. Lewis,² be disturbed in this disorder (Harrison, 1999; McCarley and Pat Levitt*³ et al., 1999). In particular, a convergence of observations *Department of Neurobiology from clinical, neuroimaging, and postmortem studies ² Departments of Psychiatry and Neuroscience have implicated the dorsal prefrontal cortex (PFC) as a ³ PittArray major locus of dysfunction in schizophrenia (Weinberger University of Pittsburgh School of Medicine et al., 1986; Selemon et al., 1995; Andreasen et al., 1997; Pittsburgh, Pennsylvania 15261 Bertolino et al., 2000). Abnormal PFC function probably contributes to many of the cognitive disturbances in schizophrenia and appears to be related to altered syn- aptic structure and/or function in this cortical region. Summary For example, in subjects with schizophrenia, reductions in gray matter volume in the dorsal PFC have been ob- Microarray expression profiling of prefrontal cortex served in neuroimaging studies (Goldstein et al., 1999; from matched pairs of schizophrenic and control sub- Sanfilipo et al., 2000), and these volumetric changes jects and hierarchical data analysis revealed that tran- are associated with an increase in cell packing density scripts encoding proteins involved in the regulation (Selemon et al., 1995, 1998; Lewis and Lieberman, 2000) of presynaptic function (PSYN) were decreased in all but no change in total neuron number in the PFC (Pak- subjects with schizophrenia. Genes of the PSYN group kenberg, 1993).
    [Show full text]
  • Frontiersin.Org 1 April 2015 | Volume 9 | Article 123 Saunders Et Al
    ORIGINAL RESEARCH published: 28 April 2015 doi: 10.3389/fnins.2015.00123 Influx mechanisms in the embryonic and adult rat choroid plexus: a transcriptome study Norman R. Saunders 1*, Katarzyna M. Dziegielewska 1, Kjeld Møllgård 2, Mark D. Habgood 1, Matthew J. Wakefield 3, Helen Lindsay 4, Nathalie Stratzielle 5, Jean-Francois Ghersi-Egea 5 and Shane A. Liddelow 1, 6 1 Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, Australia, 2 Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark, 3 Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, 4 Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland, 5 Lyon Neuroscience Research Center, INSERM U1028, Centre National de la Recherche Scientifique UMR5292, Université Lyon 1, Lyon, France, 6 Department of Neurobiology, Stanford University, Stanford, CA, USA The transcriptome of embryonic and adult rat lateral ventricular choroid plexus, using a combination of RNA-Sequencing and microarray data, was analyzed by functional groups of influx transporters, particularly solute carrier (SLC) transporters. RNA-Seq Edited by: Joana A. Palha, was performed at embryonic day (E) 15 and adult with additional data obtained at University of Minho, Portugal intermediate ages from microarray analysis. The largest represented functional group Reviewed by: in the embryo was amino acid transporters (twelve) with expression levels 2–98 times Fernanda Marques, University of Minho, Portugal greater than in the adult. In contrast, in the adult only six amino acid transporters Hanspeter Herzel, were up-regulated compared to the embryo and at more modest enrichment levels Humboldt University, Germany (<5-fold enrichment above E15).
    [Show full text]
  • List & Label Preview File
    L I N A R I S I n f o r m a t i o n B I O L O G I S C H E P R O D U K T E PRIMÄRANTIKÖRPER-Veterinär erkennen: Maus, verschiedene Labels alphabetisch geordnet Beschreibung Format Klon Wirt Isotyp Anwendung Menge ME Kat.Nr. Description Format Clone Host Isotype Application Quantity Cat.No. Mouse Anti-Cardiolipin Ig's -ve control for ELISA 1 ml ADI-5502 IgG Mouse 0,5 mg ADI-AMPT11-M-500 Anti-Cardiolipin Ig's +ve control for ELISA polyclonal Mouse 1 ml ADI-5503 CD27 PE (Armenian Hamster IgG1) Hamster 50 tests ADI-MCD027-PE Monoclonal Anti-VSV-G-Cy conjugate for Mouse 0,1 mg ADI-VSV11-Cy Immunofluorescence Interleukin-4 IgG Mouse 0,1 mg ADI-AB-10710 Anti-Myelin Oligodendrocyte Glycoprotein IgG Mouse 0,1 mg ADI-AB-19910 CD160 mAb, PE, , (mouse IgG2bk) Mouse 50 tests ADI-MCD160-PE CD81, Purified (mouse IgG1) Mouse 0,1 mg ADI-MCD081-UL Interleukin-2 receptor IgG Rat 0,1 mg ADI-AB-10310 Interleukin-2 IgG Rat 0,1 mg ADI-AB-10510 Interleukin-4 IgG Rat 0,1 mg ADI-AB-10810 Interleukin-10 IgG Rat 0,1 mg ADI-AB-11310 Interleukin-12p40 IgG Rat 0,1 mg ADI-AB-11410 CTLA-4 IgG Rat 0,1 mg ADI-AB-11610 CD80 IgG Rat 0,1 mg ADI-AB-13310 CD11a IgG Rat 0,1 mg ADI-AB-13510 CD11b-FITC IgG Rat 0,1 mg ADI-AB-13610 B220 IgG Rat 0,1 mg ADI-AB-13910 CD90 Thy-1.1 IgG Rat 0,1 mg ADI-AB-14010 CD90 Thy-1.2 IgG Rat 0,1 mg ADI-AB-14110 CD90 Thy-1 IgG Rat 0,1 mg ADI-AB-14210 CD4 IgG Rat 0,1 mg ADI-AB-16510 IFN-gamma IgG Rat 0,1 mg ADI-AB-16610 CD3 IgG Rat 0,1 mg ADI-AB-17510 Interleukin-12p75 IgG Rat 0,1 mg ADI-AB-20910 CD8b , PE-Cy5 (Clone CT-CD8b) (rat IgG2a) Rat 50 tests
    [Show full text]
  • Maestra En Ciencias Biológicas
    UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO FACULTAD DE BIOLOGÍA Programa institucional de Maestría en Ciencias Biológicas “Identificación de genes asociados a la síntesis de magnetita en la tortuga negra Chelonia agassizii.” TESIS QUE PARA OBTENER EL GRADO DE: Maestra en Ciencias Biológicas PRESENTA: Biol. María Guadalupe Rodríguez Jiménez Directora de Tesis: Dra. Alma Lilia Fuentes Farías Co-director: Dr. Jesús Campos García Morelia, Michoacán. Marzo del 2014 1 AGRADECIMIENTOS A Dios por darme la dicha de tener una hermosa familia, a mis padres y hermanos por todo el apoyo incondicional durante todos estos años y por haber compartido conmigo momentos inolvidables. A la Dra. Alma Lilia Fuentes Farías y al Dr. Gabriel Gutiérrez Ospina por darme el espacio y la oportunidad de integrarme a su equipo de trabajo, por todo el apoyo brindado y el esfuerzo dedicado al proyecto durante todo este tiempo. Al Dr. Jesús Campos García por recibirme en su Laboratorio de Biotecnología Microbiana en el IIQB, por las horas incansables de trabajo y esfuerzo dedicado al proyecto. Al Dr. Alejandro Bravo Patiño y a la Dra. Esperanza Meléndez Herrera, por sus valiosos comentarios y sugerencias que sin duda enriquecieron de manera sustancial al trabajo. A la M.C. Alma Laura Díaz Pérez, por el apoyo brindado, sus valiosas aportaciones y sugerencias durante la fase experimental. Al Dr. Jesús Ramírez Santos, por las sugerencias y el apoyo técnico brindado durante el proyecto. Al Dr. Irvin Jácome y al Dr. Víctor Meza por el apoyo brindado en la fase de expresión de genes en el trabajo. A todos mis amigos, compañeros de laboratorio por su apoyo y compañía.
    [Show full text]
  • Roles of the Plant Cell Wall in Powdery Mildew Disease
    Roles of the plant cell wall in powdery mildew disease resistance in Arabidopsis thaliana: PMR5 (POWDERY MILDEW RESISTANT 5) affects the acetylation of cell wall pectin By Candice Cherk Lim A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Plant Biology in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Shauna Somerville, Chair Professor Patricia Zambryski Associate Professor Mary Wildermuth Professor James Berger Spring 2013 Abstract Roles of the plant cell wall in powdery mildew disease resistance in Arabidopsis thaliana: PMR5 (POWDERY MILDEW RESISTANT 5) affects the acetylation of cell wall pectin by Candice Cherk Lim Doctor of Philosophy in Plant Biology University of California, Berkeley Professor Shauna Somerville, Chair The pmr5 (powdery mildew resistant 5) mutant was found in a screen for genes involved in susceptibility to Golovinomyces cichoracearum, a biotrophic pathogen that infects Arabidopsis. PMR5 is a member of the TBL (TRICHOME BIREFRINGENCE LIKE) family, which is composed of 46 functionally uncharacterized plant-specific proteins. Initial characterization of this mutant showed that pmr5-mediated disease resistance acts independently of the salicylic acid, jasmonic acid, and ethylene signal transduction pathways, and that there are changes in the pmr5 cell wall that may be linked to the gain of resistance in the mutant. Specifically, PMR5 may be affecting cell wall pectin by acetylation. Characterization of the pmr5 cell wall has revealed changes in pectin composition and a decrease in acetylation. This is corroborated by the ability of heterologously expressed PMR5 protein to bind to pectin, with decreased binding affinity to acetylated pectin.
    [Show full text]
  • Chapter 2: a Technique for Generating Unbiased Whole Genome
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Massively Parallel Polymerase Cloning and Genome Sequencing of Single Cells Using the Microwell Displacement Amplification System (MIDAS) / Permalink https://escholarship.org/uc/item/8kn4n1wd Author Gole, Jeffrey Publication Date 2013 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Massively Parallel Polymerase Cloning and Genome Sequencing of Single Cells Using the Microwell Displacement Amplification System (MIDAS) A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioengineering by Jeffrey Gole Committee in charge: Professor Kun Zhang, Chair Professor Vineet Bafna Professor Michael Heller Professor Xiaohua Huang Professor Yu-Hwa Lo 2013 Copyright Jeffrey Gole, 2013 All rights reserved The Dissertation of Jeffrey Gole is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair University of California, San Diego 2013 iii DEDICATION For my parents iv TABLE OF CONTENTS SIGNATURE PAGE………………………………………………………………....iii DEDICATION ................................................................................................... iv TABLE OF CONTENTS ....................................................................................v LIST OF FIGURES.......................................................................................... vii LIST OF TABLES............................................................................................viii
    [Show full text]
  • SLC39A14 Gene Solute Carrier Family 39 Member 14
    SLC39A14 gene solute carrier family 39 member 14 Normal Function The SLC39A14 gene provides instructions for making a protein that transports the element manganese across cell membranes. Manganese is important for many cellular functions, but large amounts are toxic, particularly to brain cells. The SLC39A14 protein is found in the membranes surrounding several types of cells, as well as in the membranes of structures within these cells. The protein is thought to transport excess manganese from the blood into liver cells so that it can be removed from the body through bile. Bile is a substance produced by the liver that is important for digestion and the removal of waste products. The SLC39A14 protein may also transport other elements, including zinc, iron, and cadmium, across cell membranes. The importance of this transport in the body is not well understood. Health Conditions Related to Genetic Changes Hypermanganesemia with dystonia At least five SLC39A14 gene mutations have been found to cause hypermanganesemia with dystonia 2, a condition that begins in early childhood and is characterized by high levels of manganese in the blood and brain (hypermanganesemia), involuntary tensing of the muscles (dystonia), and other movement problems. These mutations impair the transport of manganese into liver cells. As a result, the element cannot be removed from the body through bile. The excess manganese builds up in the blood and subsequently in brain cells, particularly cells in a region of the brain that helps control movement. High levels
    [Show full text]
  • Bayesian Determination of Disease Associated Differences in Haplotype Blocks
    American Journal of Bioinformatics 1 (1): 20-29, 2012 ISSN 1948-9862 © 2012 Science Publications Bayesian Determination of Disease Associated Differences in Haplotype Blocks 1Ivan Kozyryev and 2Jing Zhang 1Department of Physics, Faculty of Arts and Sciences, Harvard University, Cambridge, MA, USA 2Department of Statistics, Faculty of Arts and Sciences, Yale University, New Haven, CT, USA Abstract: Problem statement: While experimental ascertainment of haplotype blocks in the genome- scale case-control studies is expensive, accurate computational phasing is still a daunting task for bioinformatics approaches. We used a statistical method to determine differences, potentially associated with a certain disease, in linkage disequilibrium block boundaries in whole-genome Single Nucleotide Polymorphisms (SNPs) data. Approach: We utilized a Bayesian model for calculating the posterior probabilities of the block boundaries in the SNPs data and used Metropolis-Hastings algorithm to sample from that posterior distribution. Our method was applied to search for haplotype- block boundary differences associated with two autoimmune diseases: Type I Diabetes (T1D) and Rheumatoid Arthritis (RA). Results: We located the regions on chromosome 6 with significant control-case difference in haplotype blocks around the SNPs and genes that were previously known to be associated with T1D and RA (in the HLA complex), as well as around genes whose association with the autoimmune diseases should be further explored in future studies. Conclusion/Recommendations: The statistical approach explored in this study provides an efficient and accurate way to study connection of haplotype-block differences to multiple important diseases. Key words: Linkage disequilibrium, autoimmune diseases, HLA complex, type 1 diabetes, rheumatoid arthritis INTRODUCTION be thought of as “tiny typos” in the genome with one base being replaced by another.
    [Show full text]
  • Functional Characterisation of the Barley ZIP7 Zinc Transporter
    Functional characterisation of the barley ZIP7 zinc transporter Jingwen Tiong B. Science (Hons), The University of Adelaide A thesis submitted for the degree of Doctor of Philosophy The University of Adelaide Faculty of Sciences School of Agriculture, Food & Wine Waite Campus February 2012 I Contents List of figures ......................................................................................................................... VI List of tables ......................................................................................................................... VII Abstract ............................................................................................................................... VIII Declaration .............................................................................................................................. X Acknowledgements ............................................................................................................... XI Glossary of abbreviations .................................................................................................. XIII Chapter 1: Literature Review ................................................................................................. 1 1.1 Introduction ...................................................................................................................... 1 1.2 Improvement of plant Zn nutrition and biofortification .................................................. 3 1.2.1 Application of Zn fertilisers as an agronomic
    [Show full text]